Cargando…
New developments in locally advanced nonsmall cell lung cancer
Locally advanced nonsmall cell lung cancer, due to its varying prognosis, is grouped according to TNM stage IIIA, IIIB and IIIC. Developments over the last 3 years have been focused on the integration of immunotherapy into the combination treatment of a locally definitive therapy (surgery or radioth...
Autores principales: | Huber, Rudolf M., Kauffmann-Guerrero, Diego, Hoffmann, Hans, Flentje, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488500/ https://www.ncbi.nlm.nih.gov/pubmed/33952600 http://dx.doi.org/10.1183/16000617.0227-2020 |
Ejemplares similares
-
Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017) -
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020) -
How to handle oligometastatic disease in nonsmall cell lung cancer
por: Eichhorn, Florian, et al.
Publicado: (2021) -
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer
por: Abdayem, Pamela, et al.
Publicado: (2021) -
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2019)